EVFM - Evofem Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EVFM is currently covered by 2 analysts

Evofem Biosciences's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of EVFM is 66.67% BUY and 33.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.67% with an average time for these price targets to be met of 31 days.

Highest price target for EVFM is $45, Lowest price target is $45.

Most recent stock forecast was given by ANNABEL SAMIMY from STIFEL on 12-Oct-2022. First documented stock forecast 19-Mar-2018.

Best performing analysts who are covering EVFM - Evofem Biosciences:

Jeffrey Hung Leland Gershell Annabel Samimy Raghuram Selvaraju David Amsellem

Currently out of the existing stock ratings of EVFM, 2 are a BUY (66.67%), 1 are a HOLD (33.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$75

3 years 11 months 3 days ago
(12-Oct-2022)

0/1 (0%)

$39.15 (109.21%)

Sell

$0.75

$0.6 (400.00%)

$8.55

4 years 2 months ago
(15-Jul-2022)

2/6 (33.33%)

$1.36 (30.29%)

17

Buy

$30

$29.97 (99900.00%)

4 years 3 months 21 days ago
(25-May-2022)

1/1 (100%)

$-15 (-33.33%)

117

Buy

$30

$29.85 (19900.00%)

4 years 9 months 29 days ago
(17-Nov-2021)

1/2 (50%)

$2.79 (127.96%)

21

Buy

$300

$299.82 (166566.67%)

6 years 9 months 12 days ago
(03-Dec-2019)

0/1 (0%)

$192.9 (180.11%)

Show more analysts

Please expand the browser size to see the chart

What is EVFM (Evofem Biosciences) average time for price targets to be met?

On average it took 31 days for the stock forecasts to be reached, with an average price target met ratio of 36.67%.

Which analyst most recently updated their price target on EVFM (Evofem Biosciences)?

Annabel Samimy

Which analyst has the current lower performing score on EVFM (Evofem Biosciences) with a proven track record?

DAVID AMSELLEM

Which analyst has the most public recommendations on EVFM (Evofem Biosciences)?

Annabel Samimy works at STIFEL and has 7 price targets and 8 ratings on EVFM

Which analyst is the currently most bullish on EVFM (Evofem Biosciences)?

Leland Gershell with the highest potential upside of $299.82

Which analyst is the currently most reserved on EVFM (Evofem Biosciences)?

Annabel Samimy with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?